Christopher Cogle MD
Hematologic Oncology
Professor of Medicine, University of Florida
Join to View Full Profile
1515 SW Archer RoadGainesville, FL 32608
Phone+1 352-273-7832
Fax+1 352-273-5006
Dr. Cogle is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a board certified medical oncologist with clinical specialization in hematological malignancies and blood & marrow transplant. My laboratory research is focused on drug development for AML and MDS, oncolytic virotherapy for cancer and GVHD, and using cancer genomics for personalizing treatment for cancer patients. I've invented new epidemiological tools for improved cancer case identification in large populations. In healthy policy, I chair the Florida Cancer Council and am a member of the National Academies National Cancer Policy Forum.
Clinical Expertise
- Sarcomas, Acute myeloid leukemia, Myelodysplastic syndromes , Myeloproliferative neoplasms, Cancer genetics, Computational biology, Drug development, Aplastic anemia, Bone marrow failure syndromes, Myeloproliferative disorders, Stem cell transplantation
Education & Training
Duke University HospitalPost-Doctoral Fellowship, 2003 - 2003
University of FloridaFellowship, Hematology and Medical Oncology, 2000 - 2003- University of FloridaResidency, Internal Medicine, 1997 - 2000
- University of Florida College of MedicineClass of 1997
Certifications & Licensure
FL State Medical License 1998 - 2027
GA State Medical License 2008 - 2010
NC State Medical License 2003 - 2004
American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Phase I Clinical Trial of OXi4503 for Relapsed and Refractory AML and MDS Start of enrollment: 2011 Feb 01
- iCare for Cancer Patients Start of enrollment: 2015 Jun 26
- Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA Start of enrollment: 2015 Dec 02
- Join now to see all
Publications & Presentations
PubMed
- Medicaid and the Promise for Cure.Sophie Cain Miller, Mohammad H Dar, S Maria E Finnell, Douglas G Fish, Christopher R Cogle
JAMA Pediatrics. 2025-02-01 - Long-read epigenomic diagnosis and prognosis of Acute Myeloid Leukemia.Jatinder Lamba, Francisco Marchi, Marieke Landwehr, Ann-Kathrin Schade, Vivek Shastri
Research Square. 2024-12-12 - Participation in Tobacco Cessation Programs Among Medicaid Managed Care Enrollees in Florida.Rahma S Mkuu, Casey C Glymph, Peyton A Lurk, Madison R McCraney, Jennifer H LeLaurin
Healthcare. 2024-11-20
Journal Articles
- Clinical Application of Computational Methods in Precision OncologyMia A Levy, Christopher R Cogle, JAMA Oncology
- Functional Genomic Landscape of Acute Myeloid LeukaemiaMarc M Loriaux, Christopher R Cogle, Patricia Kropf, Daniel A Pollyea, Uma Borate, Michael W Deininger, Nature
Abstracts/Posters
- Diagnostic Testing Patterns and Concordance with World Health Organization (WHO) Criteria for Patients (Pts) with Newly Diagnosed (ND) Myelodysplastic Syndromes (MDS) ...Christopher R. Cogle, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- CRISPR Dropout Screens Identify DHODH, PIK3C3, and Crkl as Potential Therapeutic Targets in Acute Myeloid LeukemiaChristopher R. Cogle, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Predicting Response to Dasatinib Using a Computational Model and Its Validation: A Beat AML Project Study2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- WT1 and BCORL1 Identified By Computational Biology Modeling Analysis of Patient Genomics Are Novel Predictors of Response to Azacitidine (AZA) and Lenalidomide (LEN) T...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Predicting Response to BET Inhibitor in Combination with Palbociclib / Sorafenib Using a Computational Model and Its Validation: A Beat AML Project Study2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Authored Content
- Clinical Application of Computational Methods in Precision OncologyMay 2020
- Clinical Application of Computational Methods in Precision OncologyMay 2020
Press Mentions
OncoMyx Announces Exclusive Option to License Intellectual Property Rights for Myxoma Virus Technology from University of FloridaJune 15th, 2021
Grant Support
- Defining The Human HemangioblastNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2009
Committees
- Member, National Cancer Policy Forum 2017 - Present
- Chairperson, Florida Cancer Control and Research Advisory Council (CCRAB) 2016 - Present
Professional Memberships
- Member
External Links
- Websitehttp://cogle.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
